Physician
Pulmonology
Dr. David H. Witty, MD
|
|
Give Review
David Witty is an expert in the field of Pulmonology. He went to University of Arkansas for Medical Sciences. University of Arkansas for Medical Sciences is ranked 83/35 in Research/PrimaryCare. He has 1 awards "Meaningful Use Stage 1 Certification". David H. Witty is also published. He has 20 publications published. The lastest publication: "Advances in the design of 5-HT6 receptor ligands with therapeutic potential.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Effect of direct injection of melanin-concentrating hormone into the paraventricular nucleus: further evidence for a stimulatory role in the adrenal axis via SLC-1.
- Society for Anti-infective Pharmacology--Ninth International Symposium. 3-4 July 1999, Birmingham, UK.
- Anti-infective research.
- 27th National Medicinal Chemistry Symposium.
- Appropriate selection of biochemical targets is one of the most important driver of cost-effectiveness in the discovery of new medicines. Preface.
- Beginning of the ''numbers'' era of medicinal chemistry. Preface.
- Progress in medicinal chemistry. Preface.
- Medicinial chemistry. Preface.
- Advances in the design of 5-HT6 receptor ligands with therapeutic potential.
- Drug discovery projects. Preface.
- Potent oxadiazole CGRP receptor antagonists for the potential treatment of migraine.
- Tricyclic azepine derivatives as selective brain penetrant 5-HT6 receptor antagonists.
- The antimicrobial natural product chuangxinmycin and some synthetic analogues are potent and selective inhibitors of bacterial tryptophanyl tRNA synthetase.
- Unified route to the palmarumycin and preussomerin natural products. Enantioselective synthesis of (-)-preussomerin G.
- Biphenyl amides and isosteres as MCH R1 antagonists.
- Discovery of potent and stable conformationally constrained analogues of the MCH R1 antagonist SB-568849.
- SAR of biphenyl carboxamide ligands of the human melanin-concentrating hormone receptor 1 (MCH R1): discovery of antagonist SB-568849.
- Bicyclic heteroarylpiperazines as selective brain penetrant 5-HT6 receptor antagonists.
- Definition of the heterocyclic pharmacophore of bacterial methionyl tRNA synthetase inhibitors: potent antibacterially active non-quinolone analogues.
Schools
Univ Of Ms Sch Of Med
University Hospital Of Arkansas
University Ok Health Science Center
Procedures Preformed
- Bronchoscopy
- Thoracentesis
- Ventilation Management
Conditions Treated
- Acidosis
- Alkalosis
- Asbestosis
- Asthma
- View All
Doctors Specialties
- Pulmonology
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
Education
-
University of Oklahoma Health Sciences Center -
University of Arkansas for Medical Sciences -
University of Mississippi School of Medicine
Drug Facts
| NPI NUMBER | 1114984374 | |
| NPPES Provider LastName | WITTY | |
| NPPES Provider FirstName | DAVID | |
| NPPES Provider ZIPCode | 388014905 | |
| NPPES Provider State | MS | |
| Specialty Description | Pulmonary Disease | |
| Total Claim Count | 2295.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1114984374 |
| Last Name Of The Provider | WITTY |
| First Name Of The Provider | DAVID |
| View All |
Similar Doctors
|
|
Dr. Robert N. Stewart, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul M. Perry, MD |
|
|
Dr. David A. Reed, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lyndon H. Perkins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David B. Moore Jr., MD |
|
|
Dr. David G. Chase Sr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James A. Rish, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevin C. Harbour, MD
This Doctor is OpenDoctor Recommended.
|